Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review

E Webb, I Rigby, M Michelen, A Dagens, V Cheng… - BMJ global …, 2022 - gh.bmj.com
Background Monkeypox (MPX) is an important human Orthopoxvirus infection. There has
been an increase in MPX cases and outbreaks in endemic and non-endemic regions in …

An evaluation of global Chikungunya clinical management guidelines: a systematic review

E Webb, M Michelen, I Rigby, A Dagens… - …, 2022 - thelancet.com
Background Chikungunya virus (CHIKV) has expanded its geographical reach in recent
decades and is an emerging global health threat. CHIKV can cause significant morbidity and …

In vitro and in vivo studies reveal α-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus

P Patil, M Agrawal, S Almelkar, MK Jeengar, A More… - Virology Journal, 2021 - Springer
Background Chikungunya virus (CHIKV), a serious health problem in several tropical
countries, is the causative agent of chikungunya fever. Approved antiviral therapies or …

Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission

YM Wang, JW Lu, CC Lin, YF Chin, TY Wu, LI Lin… - Antiviral research, 2016 - Elsevier
Chikungunya disease results from an infection with the arbovirus, chikungunya virus
(CHIKV). Symptoms of CHIKV include fever and persistent, severe arthritis. In recent years …

Growth in chikungunya virus-related research in ASEAN and South Asian countries from 1967 to 2022 following disease emergence: a bibliometric and graphical …

F Sofyantoro, A Frediansyah, DS Priyono… - Globalization and …, 2023 - Springer
Abstract Background ASEAN (Association of Southeast Asian Nations) is composed of ten
Southeast Asian countries bound by socio-cultural ties that promote regional peace and …

Chikungunya virus and its envelope protein E2 induce hyperalgesia in mice: Inhibition by anti-E2 monoclonal antibodies and by targeting TRPV1

CZ Segato-Vendrameto, C Zanluca, AZ Zucoloto… - Cells, 2023 - mdpi.com
Chikungunya virus is an arthropod-borne infectious agent that causes Chikungunya fever
disease. About 90% of the infected patients experience intense polyarthralgia, affecting …

Computational approach towards exploring potential anti-chikungunya activity of selected flavonoids

SS Seyedi, M Shukri, P Hassandarvish, A Oo… - Scientific reports, 2016 - nature.com
Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that causes chikungunya
infection in humans. Despite the widespread distribution of CHIKV, no antiviral medication or …

Comprehensive innate immune profiling of chikungunya virus infection in pediatric cases

D Michlmayr, TR Pak, AH Rahman… - Molecular systems …, 2018 - embopress.org
Chikungunya virus (CHIKV) is a mosquito‐borne alphavirus that causes global epidemics of
debilitating disease worldwide. To gain functional insight into the host cellular genes …

Extensive immunoinformatics study for the prediction of novel peptide-based epitope vaccine with docking confirmation against envelope protein of Chikungunya virus …

SS Bappy, S Sultana, J Adhikari… - Journal of …, 2021 - Taylor & Francis
Chikungunya virus (CHIKV) instigating Chikungunya fever is a global infective menace
resulting in high fever, weakened joint-muscle pain, and brain inflammation. Inaccessibility …

Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses

JVJ Silva Jr, TRR Lopes, EF de Oliveira-Filho… - Acta tropica, 2018 - Elsevier
Emerging and re-emerging viral infections transmitted by insect vectors (arthopode-borne
viruses, arbovirus) are a serious threat to global public health. Among them, yellow fever …